Manufacturer record
Intas Pharmaceuticals Ltd.Samardung Road: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Intas Pharmaceuticals Ltd.Samardung Road (Sikkim) were declared Not of Standard Quality between February 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: N2600542, Tamsulosin Hydrochloride Modified Release Tablets (exp Jan 2029). SDTL, Uttarakhand (state lab) found it not of standard quality: One extra peak of Dutasteride found on Chromatogram. Listed in the September 2026 alert.
Records by type
5 records linked to Intas Pharmaceuticals Ltd.Samardung Road in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Tamsulosin Hydrochloride Modified Release Tablets | Batch N2600542Mfg Feb 2026 · Exp Jan 2029 | One extra peak of Dutasteride found on Chromatogram.Other | SDTL, UttarakhandState lab | Sep 2026 |
| Tamsulosin Hydrochloride (Modified Release) + Dutasteride Tablets | Batch N2503564Mfg Nov 2025 · Exp Oct 2028 | ASSAY OF DUTASTERIDE I.P. ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab | Sep 2026 |
| Gabapentin Tablets IP 100 mg | Batch N2504093Mfg Dec 2025 · Exp Nov 2027 | ASSAY OF GABAPENTIN I.P. ?Less than prescribed limit.Assay | SDTL, UttarakhandState lab | Sep 2026 |
| Levetiracetam Tablets IP 500 mg | Batch N2601077Mfg Apr 2026 · Exp Mar 2029 | The sample does not conform to IP, in respect of DissolutionDissolution | LUCKNOW LABState lab | Aug 2026 |
| Baclofen Tablets IP 10 mg | Batch N2501643Mfg May 2025 · Exp Apr 2028 | The sample does not conform to I.P with respect to the test for Lactam.Other | CDTL, IndoreCDSCO lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.